Loading…

Evaluation of the Cepheid Xpert Clostridium difficile Epi Assay for Diagnosis of Clostridium difficile Infection and Typing of the NAP1 Strain at a Cancer Hospital

Clostridium difficile is the most common cause of health care-associated diarrhea. Accurate and rapid diagnosis is essential to improve patient outcome and prevent disease spread. We compared our two-step diagnostic algorithm, an enzyme immunoassay for glutamate dehydrogenase (GDH) followed by the c...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Clinical Microbiology 2010-12, Vol.48 (12), p.4519-4524
Main Authors: Babady, N. Esther, Stiles, Jeffrey, Ruggiero, Phyllis, Khosa, Perminder, Huang, David, Shuptar, Susan, Kamboj, Mini, Kiehn, Timothy E
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c496t-ae8ef520fd70d4761a95b9f53125a9afbbda32d2092a2de1b0e2e2467b3cda773
cites cdi_FETCH-LOGICAL-c496t-ae8ef520fd70d4761a95b9f53125a9afbbda32d2092a2de1b0e2e2467b3cda773
container_end_page 4524
container_issue 12
container_start_page 4519
container_title Journal of Clinical Microbiology
container_volume 48
creator Babady, N. Esther
Stiles, Jeffrey
Ruggiero, Phyllis
Khosa, Perminder
Huang, David
Shuptar, Susan
Kamboj, Mini
Kiehn, Timothy E
description Clostridium difficile is the most common cause of health care-associated diarrhea. Accurate and rapid diagnosis is essential to improve patient outcome and prevent disease spread. We compared our two-step diagnostic algorithm, an enzyme immunoassay for glutamate dehydrogenase (GDH) followed by the cytotoxin neutralization test (CYT) with a turnaround time of 24 to 48 h, versus the Cepheid Xpert C. difficile Epi assay, a PCR-based assay with a turnaround time of 90%). The excellent sensitivity and specificity and the rapid turnaround time of the Xpert PCR assay as well as its strain-typing capability make it an attractive option for diagnosis of C. difficile infection.
doi_str_mv 10.1128/JCM.01648-10
format article
fullrecord <record><control><sourceid>proquest_pasca</sourceid><recordid>TN_cdi_pascalfrancis_primary_23597539</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>872125669</sourcerecordid><originalsourceid>FETCH-LOGICAL-c496t-ae8ef520fd70d4761a95b9f53125a9afbbda32d2092a2de1b0e2e2467b3cda773</originalsourceid><addsrcrecordid>eNptkUtv1DAUhSMEotPCjjVYSIgNKX7k5Q3SKB1oUXlIbaXurJvYTlwlcbCTovk9_FGczrSAxMqS7-dzzvWJohcEHxNCi_efyy_HmGRJERP8KFoRzIs4y_D142iFMU9jQlh-EB16f4MxSZI0fRodUMwTVmR4Ff3a3EI3w2TsgKxGU6tQqcZWGYmuR-UmVHbWT85IM_dIGq1NbTqFNqNBa-9hi7R16MRAM1hv_CLx_wdng1b1nQsMEl1uRzM094Zf198JupgcmDCdEKAShlo5dGr9aCbonkVPNHRePd-fR9HVx81leRqff_t0Vq7P4zrh2RSDKpROKdYyxzLJMwI8rbhOGaEpcNBVJYFRGXanQKUiFVZU0STLK1ZLyHN2FH3Y6Y5z1StZqyFk6sToTA9uKywY8e9kMK1o7K1gGBdJsgi83Qs4-2NWfhK98bXqOhiUnb0ochqyZBkP5LsdWTvrvVP6wYVgsdQqQq3irtZwE_CXfyd7gO97DMCbPQC-hk678IPG_-FYyvOULb6vd1xrmvancUqA78VN3YvFiIokJQv0agdpsAIaF4SuLigmDBNOcpxT9htGacIs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>872125669</pqid></control><display><type>article</type><title>Evaluation of the Cepheid Xpert Clostridium difficile Epi Assay for Diagnosis of Clostridium difficile Infection and Typing of the NAP1 Strain at a Cancer Hospital</title><source>PubMed Central (Open Access)</source><source>American Society for Microbiology Journals</source><creator>Babady, N. Esther ; Stiles, Jeffrey ; Ruggiero, Phyllis ; Khosa, Perminder ; Huang, David ; Shuptar, Susan ; Kamboj, Mini ; Kiehn, Timothy E</creator><creatorcontrib>Babady, N. Esther ; Stiles, Jeffrey ; Ruggiero, Phyllis ; Khosa, Perminder ; Huang, David ; Shuptar, Susan ; Kamboj, Mini ; Kiehn, Timothy E</creatorcontrib><description>Clostridium difficile is the most common cause of health care-associated diarrhea. Accurate and rapid diagnosis is essential to improve patient outcome and prevent disease spread. We compared our two-step diagnostic algorithm, an enzyme immunoassay for glutamate dehydrogenase (GDH) followed by the cytotoxin neutralization test (CYT) with a turnaround time of 24 to 48 h, versus the Cepheid Xpert C. difficile Epi assay, a PCR-based assay with a turnaround time of &lt;1 h. In the first phase of the study, only GDH-positive stool samples were tested by both CYT and Xpert PCR. Discordant results were resolved by toxigenic culture. In the second phase, all stool samples were tested by GDH and Xpert PCR. Only GDH-positive stools were further tested by CYT. Genotypic characterization of 45 Xpert PCR-positive stools was performed by sequencing of the tcdC gene and PCR ribotyping. In phase 1, the agreement between the GDH-CYT and the GDH-Xpert PCR was 72%. The sensitivities and specificities of GDH-CYT and GDH-Xpert PCR were 57% and 97% and 100% and 97%, respectively. In phase 2, the agreement between GDH-CYT and Xpert PCR alone was 95%. As in phase 1, sensitivity of the Xpert PCR was higher than that of the GDH-CYT. The correlation between PCR-ribotyping, sequencing, and Xpert PCR for detection of NAP1 strains was excellent (&gt;90%). The excellent sensitivity and specificity and the rapid turnaround time of the Xpert PCR assay as well as its strain-typing capability make it an attractive option for diagnosis of C. difficile infection.</description><identifier>ISSN: 0095-1137</identifier><identifier>EISSN: 1098-660X</identifier><identifier>DOI: 10.1128/JCM.01648-10</identifier><identifier>PMID: 20943860</identifier><identifier>CODEN: JCMIDW</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Bacterial Proteins - genetics ; Bacteriological Techniques - methods ; Bacteriology ; Biological and medical sciences ; Cancer Care Facilities ; Clostridium difficile ; Clostridium difficile - classification ; Clostridium difficile - isolation &amp; purification ; Clostridium Infections - diagnosis ; Clostridium Infections - microbiology ; Cross Infection - diagnosis ; Cross Infection - microbiology ; Enzyme-Linked Immunosorbent Assay - methods ; Feces - microbiology ; Fundamental and applied biological sciences. Psychology ; Genotype ; Humans ; Medical sciences ; Microbiology ; Miscellaneous ; Polymerase Chain Reaction - methods ; Repressor Proteins - genetics ; Ribotyping ; Sensitivity and Specificity ; Tumors</subject><ispartof>Journal of Clinical Microbiology, 2010-12, Vol.48 (12), p.4519-4524</ispartof><rights>2015 INIST-CNRS</rights><rights>Copyright © 2010, American Society for Microbiology 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c496t-ae8ef520fd70d4761a95b9f53125a9afbbda32d2092a2de1b0e2e2467b3cda773</citedby><cites>FETCH-LOGICAL-c496t-ae8ef520fd70d4761a95b9f53125a9afbbda32d2092a2de1b0e2e2467b3cda773</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3008447/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3008447/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,3186,3187,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23597539$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20943860$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Babady, N. Esther</creatorcontrib><creatorcontrib>Stiles, Jeffrey</creatorcontrib><creatorcontrib>Ruggiero, Phyllis</creatorcontrib><creatorcontrib>Khosa, Perminder</creatorcontrib><creatorcontrib>Huang, David</creatorcontrib><creatorcontrib>Shuptar, Susan</creatorcontrib><creatorcontrib>Kamboj, Mini</creatorcontrib><creatorcontrib>Kiehn, Timothy E</creatorcontrib><title>Evaluation of the Cepheid Xpert Clostridium difficile Epi Assay for Diagnosis of Clostridium difficile Infection and Typing of the NAP1 Strain at a Cancer Hospital</title><title>Journal of Clinical Microbiology</title><addtitle>J Clin Microbiol</addtitle><description>Clostridium difficile is the most common cause of health care-associated diarrhea. Accurate and rapid diagnosis is essential to improve patient outcome and prevent disease spread. We compared our two-step diagnostic algorithm, an enzyme immunoassay for glutamate dehydrogenase (GDH) followed by the cytotoxin neutralization test (CYT) with a turnaround time of 24 to 48 h, versus the Cepheid Xpert C. difficile Epi assay, a PCR-based assay with a turnaround time of &lt;1 h. In the first phase of the study, only GDH-positive stool samples were tested by both CYT and Xpert PCR. Discordant results were resolved by toxigenic culture. In the second phase, all stool samples were tested by GDH and Xpert PCR. Only GDH-positive stools were further tested by CYT. Genotypic characterization of 45 Xpert PCR-positive stools was performed by sequencing of the tcdC gene and PCR ribotyping. In phase 1, the agreement between the GDH-CYT and the GDH-Xpert PCR was 72%. The sensitivities and specificities of GDH-CYT and GDH-Xpert PCR were 57% and 97% and 100% and 97%, respectively. In phase 2, the agreement between GDH-CYT and Xpert PCR alone was 95%. As in phase 1, sensitivity of the Xpert PCR was higher than that of the GDH-CYT. The correlation between PCR-ribotyping, sequencing, and Xpert PCR for detection of NAP1 strains was excellent (&gt;90%). The excellent sensitivity and specificity and the rapid turnaround time of the Xpert PCR assay as well as its strain-typing capability make it an attractive option for diagnosis of C. difficile infection.</description><subject>Bacterial Proteins - genetics</subject><subject>Bacteriological Techniques - methods</subject><subject>Bacteriology</subject><subject>Biological and medical sciences</subject><subject>Cancer Care Facilities</subject><subject>Clostridium difficile</subject><subject>Clostridium difficile - classification</subject><subject>Clostridium difficile - isolation &amp; purification</subject><subject>Clostridium Infections - diagnosis</subject><subject>Clostridium Infections - microbiology</subject><subject>Cross Infection - diagnosis</subject><subject>Cross Infection - microbiology</subject><subject>Enzyme-Linked Immunosorbent Assay - methods</subject><subject>Feces - microbiology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Genotype</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Microbiology</subject><subject>Miscellaneous</subject><subject>Polymerase Chain Reaction - methods</subject><subject>Repressor Proteins - genetics</subject><subject>Ribotyping</subject><subject>Sensitivity and Specificity</subject><subject>Tumors</subject><issn>0095-1137</issn><issn>1098-660X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNptkUtv1DAUhSMEotPCjjVYSIgNKX7k5Q3SKB1oUXlIbaXurJvYTlwlcbCTovk9_FGczrSAxMqS7-dzzvWJohcEHxNCi_efyy_HmGRJERP8KFoRzIs4y_D142iFMU9jQlh-EB16f4MxSZI0fRodUMwTVmR4Ff3a3EI3w2TsgKxGU6tQqcZWGYmuR-UmVHbWT85IM_dIGq1NbTqFNqNBa-9hi7R16MRAM1hv_CLx_wdng1b1nQsMEl1uRzM094Zf198JupgcmDCdEKAShlo5dGr9aCbonkVPNHRePd-fR9HVx81leRqff_t0Vq7P4zrh2RSDKpROKdYyxzLJMwI8rbhOGaEpcNBVJYFRGXanQKUiFVZU0STLK1ZLyHN2FH3Y6Y5z1StZqyFk6sToTA9uKywY8e9kMK1o7K1gGBdJsgi83Qs4-2NWfhK98bXqOhiUnb0ochqyZBkP5LsdWTvrvVP6wYVgsdQqQq3irtZwE_CXfyd7gO97DMCbPQC-hk678IPG_-FYyvOULb6vd1xrmvancUqA78VN3YvFiIokJQv0agdpsAIaF4SuLigmDBNOcpxT9htGacIs</recordid><startdate>20101201</startdate><enddate>20101201</enddate><creator>Babady, N. Esther</creator><creator>Stiles, Jeffrey</creator><creator>Ruggiero, Phyllis</creator><creator>Khosa, Perminder</creator><creator>Huang, David</creator><creator>Shuptar, Susan</creator><creator>Kamboj, Mini</creator><creator>Kiehn, Timothy E</creator><general>American Society for Microbiology</general><general>American Society for Microbiology (ASM)</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>5PM</scope></search><sort><creationdate>20101201</creationdate><title>Evaluation of the Cepheid Xpert Clostridium difficile Epi Assay for Diagnosis of Clostridium difficile Infection and Typing of the NAP1 Strain at a Cancer Hospital</title><author>Babady, N. Esther ; Stiles, Jeffrey ; Ruggiero, Phyllis ; Khosa, Perminder ; Huang, David ; Shuptar, Susan ; Kamboj, Mini ; Kiehn, Timothy E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c496t-ae8ef520fd70d4761a95b9f53125a9afbbda32d2092a2de1b0e2e2467b3cda773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Bacterial Proteins - genetics</topic><topic>Bacteriological Techniques - methods</topic><topic>Bacteriology</topic><topic>Biological and medical sciences</topic><topic>Cancer Care Facilities</topic><topic>Clostridium difficile</topic><topic>Clostridium difficile - classification</topic><topic>Clostridium difficile - isolation &amp; purification</topic><topic>Clostridium Infections - diagnosis</topic><topic>Clostridium Infections - microbiology</topic><topic>Cross Infection - diagnosis</topic><topic>Cross Infection - microbiology</topic><topic>Enzyme-Linked Immunosorbent Assay - methods</topic><topic>Feces - microbiology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Genotype</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Microbiology</topic><topic>Miscellaneous</topic><topic>Polymerase Chain Reaction - methods</topic><topic>Repressor Proteins - genetics</topic><topic>Ribotyping</topic><topic>Sensitivity and Specificity</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Babady, N. Esther</creatorcontrib><creatorcontrib>Stiles, Jeffrey</creatorcontrib><creatorcontrib>Ruggiero, Phyllis</creatorcontrib><creatorcontrib>Khosa, Perminder</creatorcontrib><creatorcontrib>Huang, David</creatorcontrib><creatorcontrib>Shuptar, Susan</creatorcontrib><creatorcontrib>Kamboj, Mini</creatorcontrib><creatorcontrib>Kiehn, Timothy E</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of Clinical Microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Babady, N. Esther</au><au>Stiles, Jeffrey</au><au>Ruggiero, Phyllis</au><au>Khosa, Perminder</au><au>Huang, David</au><au>Shuptar, Susan</au><au>Kamboj, Mini</au><au>Kiehn, Timothy E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of the Cepheid Xpert Clostridium difficile Epi Assay for Diagnosis of Clostridium difficile Infection and Typing of the NAP1 Strain at a Cancer Hospital</atitle><jtitle>Journal of Clinical Microbiology</jtitle><addtitle>J Clin Microbiol</addtitle><date>2010-12-01</date><risdate>2010</risdate><volume>48</volume><issue>12</issue><spage>4519</spage><epage>4524</epage><pages>4519-4524</pages><issn>0095-1137</issn><eissn>1098-660X</eissn><coden>JCMIDW</coden><abstract>Clostridium difficile is the most common cause of health care-associated diarrhea. Accurate and rapid diagnosis is essential to improve patient outcome and prevent disease spread. We compared our two-step diagnostic algorithm, an enzyme immunoassay for glutamate dehydrogenase (GDH) followed by the cytotoxin neutralization test (CYT) with a turnaround time of 24 to 48 h, versus the Cepheid Xpert C. difficile Epi assay, a PCR-based assay with a turnaround time of &lt;1 h. In the first phase of the study, only GDH-positive stool samples were tested by both CYT and Xpert PCR. Discordant results were resolved by toxigenic culture. In the second phase, all stool samples were tested by GDH and Xpert PCR. Only GDH-positive stools were further tested by CYT. Genotypic characterization of 45 Xpert PCR-positive stools was performed by sequencing of the tcdC gene and PCR ribotyping. In phase 1, the agreement between the GDH-CYT and the GDH-Xpert PCR was 72%. The sensitivities and specificities of GDH-CYT and GDH-Xpert PCR were 57% and 97% and 100% and 97%, respectively. In phase 2, the agreement between GDH-CYT and Xpert PCR alone was 95%. As in phase 1, sensitivity of the Xpert PCR was higher than that of the GDH-CYT. The correlation between PCR-ribotyping, sequencing, and Xpert PCR for detection of NAP1 strains was excellent (&gt;90%). The excellent sensitivity and specificity and the rapid turnaround time of the Xpert PCR assay as well as its strain-typing capability make it an attractive option for diagnosis of C. difficile infection.</abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>20943860</pmid><doi>10.1128/JCM.01648-10</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0095-1137
ispartof Journal of Clinical Microbiology, 2010-12, Vol.48 (12), p.4519-4524
issn 0095-1137
1098-660X
language eng
recordid cdi_pascalfrancis_primary_23597539
source PubMed Central (Open Access); American Society for Microbiology Journals
subjects Bacterial Proteins - genetics
Bacteriological Techniques - methods
Bacteriology
Biological and medical sciences
Cancer Care Facilities
Clostridium difficile
Clostridium difficile - classification
Clostridium difficile - isolation & purification
Clostridium Infections - diagnosis
Clostridium Infections - microbiology
Cross Infection - diagnosis
Cross Infection - microbiology
Enzyme-Linked Immunosorbent Assay - methods
Feces - microbiology
Fundamental and applied biological sciences. Psychology
Genotype
Humans
Medical sciences
Microbiology
Miscellaneous
Polymerase Chain Reaction - methods
Repressor Proteins - genetics
Ribotyping
Sensitivity and Specificity
Tumors
title Evaluation of the Cepheid Xpert Clostridium difficile Epi Assay for Diagnosis of Clostridium difficile Infection and Typing of the NAP1 Strain at a Cancer Hospital
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T14%3A01%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20the%20Cepheid%20Xpert%20Clostridium%20difficile%20Epi%20Assay%20for%20Diagnosis%20of%20Clostridium%20difficile%20Infection%20and%20Typing%20of%20the%20NAP1%20Strain%20at%20a%20Cancer%20Hospital&rft.jtitle=Journal%20of%20Clinical%20Microbiology&rft.au=Babady,%20N.%20Esther&rft.date=2010-12-01&rft.volume=48&rft.issue=12&rft.spage=4519&rft.epage=4524&rft.pages=4519-4524&rft.issn=0095-1137&rft.eissn=1098-660X&rft.coden=JCMIDW&rft_id=info:doi/10.1128/JCM.01648-10&rft_dat=%3Cproquest_pasca%3E872125669%3C/proquest_pasca%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c496t-ae8ef520fd70d4761a95b9f53125a9afbbda32d2092a2de1b0e2e2467b3cda773%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=872125669&rft_id=info:pmid/20943860&rfr_iscdi=true